Andrew Kowalski

Andrew Kowalski, MD, FASN A summary and commentary on: Čižman B, Butler EL, Stavas J, et al. A Randomized Clinical Trial of Kidney Autologous Cell Therapy in Diabetic Kidney Disease. Clin J Am Soc Nephrol. Published January 2, 2026. doi:10.2215/CJN.0000000969 So if you have not heard, there has been some excitement in the world of kidney disease lately! A article came out in 1/2026 discussing a possible, and promising, use of stem cell therapy to address diabetic kidney disease. So why are we...

An updated version from the last post Andrew Kowalski, MD, FASN CKD remains one of the most underdiagnosed and undertreated conditions in modern medicine, affecting more than one in ten adults worldwide and dramatically increasing the risk of cardiovascular disease, kidney failure, and premature death . For decades, our therapeutic approach rested on a familiar foundation, The Big 4: Blood pressure control Renin-angiotensin system blockade Glycemic management in those with diabetes Lifestyle...

Andrew Kowalski, MD FASN I have been an advocate for exercise among CKD patients for a long time. Fortunately, there have been numerous publications showing significant benefit among CKD patients. From numerous cardiovascular benefits to evidence that it can help lower chronic inflammation and delay CKD progression. I was excited to see another study looking at physical activity and preserving kidney function. The RENIS study from Tromsø, Northern Norway , asked a clinically relevant...